Seth Klarman: portfolio of Baupost Group

Seth Klarman leads the Baupost Group, which follows a value approach and looks for securities trading below their estimated worth.

Source: 13F filing with the US Securities and Exchange Commission dated Aug 12, 2016. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included.

You are looking at Q2 2016. Go to the latest filing (Q3 2026)

7.3B USDQ2 2016
Total value of stock positions
7.3B USD
Positions
38
Share of the ten largest
74.8%

The ten largest positions Q2 2016

  1. E M C Corp Mass 21.1%▲ +9.9%
  2. Cheniere Energy Inc 15.3%unchanged
  3. Viasat Inc 11.2%unchanged
  4. Allergan PLC 6.3%▲ +16.3%
  5. Antero Res Corp 5.1%▼ −32.5%
  6. Olin Corp 3.6%unchanged
  7. Pbf Energy Inc 3.5%unchanged
  8. Citigroup 3.0%new
  9. Twenty First Centy Fox Inc 2.8%unchanged
  10. PayPal 2.8%▼ −19.8%
Total value of stock positions per quarter, Q2 2013 to Q3 2026 (peak 12.7B USD).
Choose a quarter (54 filings)

All positions Q2 2016

Positions Q2 2016 per 13F filing, 38 of 38
Symbol Weight Shares Reported value Change Held since
E M C Corp Mass 21.1% 56,961,725 1.5B USD +9.9% increased Q4 2015 3 quarters
Cheniere Energy Inc 15.3% 29,841,174 1.1B USD unchanged Q1 2014 10 quarters
Viasat Inc 11.2% 11,533,137 823.5M USD unchanged Q2 2013 or earlier 13 quarters
Allergan PLC 6.3% 2,001,978 462.6M USD +16.3% increased Q1 2016 2 quarters
Antero Res Corp 5.1% 14,505,881 376.9M USD −32.5% reduced Q3 2014 8 quarters
Olin Corp 3.6% 10,739,202 266.8M USD unchanged Q3 2015 4 quarters
Pbf Energy Inc 3.5% 10,641,175 253.0M USD unchanged Q3 2013 12 quarters
C Citigroup 3.0% 5,167,000 219.0M USD new Q2 2016 1 quarter
Twenty First Centy Fox Inc 2.8% 7,696,922 208.2M USD unchanged Q3 2015 4 quarters
PYPL PayPal 2.8% 5,664,087 206.8M USD −19.8% reduced Q3 2015 4 quarters
Twenty First Centy Fox Inc 2.7% 7,278,100 198.3M USD unchanged Q3 2015 4 quarters
Innoviva Inc 2.5% 17,610,091 185.4M USD −11.1% reduced Q1 2016 2 quarters
Keryx Biopharmaceuticals Inc 2.3% 25,791,678 170.7M USD unchanged Q1 2014 10 quarters
Theravance Biopharma Inc 2.3% 7,350,991 166.8M USD +13.1% increased Q2 2014 9 quarters
Vmware Inc 1.8% 2,252,694 128.9M USD unchanged Q1 2016 2 quarters
Atara Biotherapeutics Inc 1.6% 5,359,632 120.6M USD unchanged Q4 2014 7 quarters
Veritiv Corp 1.6% 3,044,385 114.4M USD unchanged Q3 2014 8 quarters
Forward Pharma A/S 1.3% 5,367,300 97.5M USD unchanged Q4 2014 7 quarters
Liberty Interactive Corp 1.2% 2,469,533 91.5M USD new Q2 2016 1 quarter
Chipmos Tech Bermuda Ltd 0.9% 3,751,853 67.9M USD unchanged Q2 2013 or earlier 13 quarters
Klx Inc 0.8% 2,000,000 62.0M USD unchanged Q1 2015 6 quarters
Novagold Res Inc 0.8% 9,500,000 58.1M USD −36.7% reduced Q2 2013 or earlier 13 quarters
Avis Budget Group 0.8% 1,787,227 57.6M USD new Q2 2016 1 quarter
Sunedison Semiconductor Ltd 0.7% 8,372,979 49.7M USD unchanged Q2 2014 9 quarters
American Intl Group Inc 0.7% 2,550,917 47.7M USD +20.1% increased Q2 2013 or earlier 13 quarters
Liberty Media Corp Delaware 0.6% 2,994,010 43.9M USD new Q2 2016 1 quarter
Silver Run Acquisition Corp 0.5% 3,750,000 36.8M USD new Q2 2016 1 quarter
Paratek Pharmaceuticals Inc 0.4% 2,044,498 28.4M USD +32.4% increased Q4 2014 7 quarters
Cascadian Therapeutics Inc 0.3% 25,000,000 23.6M USD new Q2 2016 1 quarter
Credit Accep Corp Mich 0.3% 100,000 18.5M USD new Q2 2016 1 quarter
RUN Sunrun 0.2% 2,848,082 16.9M USD unchanged Q3 2015 4 quarters
Och Ziff Cap Mgmt Group 0.2% 3,373,891 12.8M USD new Q2 2016 1 quarter
Liberty Media Corp Delaware 0.2% 800,000 12.0M USD new Q2 2016 1 quarter
Kindred Biosciences Inc 0.1% 3,013,848 10.7M USD unchanged Q4 2013 11 quarters
Orexigen Therapeutics Inc 0.1% 22,268,399 9.6M USD unchanged Q3 2015 4 quarters
Citigroup Inc < 0.1% 102,553,207 6.0M USD unchanged Q2 2013 or earlier 13 quarters
Novacopper Inc < 0.1% 10,600,758 5.3M USD unchanged Q2 2013 or earlier 13 quarters
Silver Run Acquisition Corp < 0.1% 1,250,000 1.4M USD new Q2 2016 1 quarter

“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.

Plus 1 position in convertible bonds and bonds worth 38.9M USD as reported – not included in the weights.

Convertible bonds and bonds, principal amount as reported. They are not stock positions and therefore do not count towards the weights.

  • Theravance Inc principal 48.2M USD 38.9M USD

Breakdown by sector

  • Financials 5.8%
  • Industrials 0.2%
  • not in our coverage 94.0%

Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.

How to read this page

  • Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
  • Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
  • Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.

All superinvestor portfolios Screener: stocks held by superinvestors

↑ ↓ select · Enter open · Esc close